Platelet disorders

Platelet Disorders: Primary Hemostasis Defects & Lab Profiles

Platelet disorders manifest as defects in primary hemostasis, which is the initial formation of a platelet plug. Clinically, primary hemostatic defects present with superficial bleeding: petechiae (pinpoint skin hemorrhages), purpura, ecchymoses, epistaxis (nosebleeds), and menorrhagia. This contrasts with secondary hemostasis defects (coagulation factor deficiencies), which present with deep tissue bleeding, such as hemarthrosis into joints.

1. Quantitative Platelet Disorders (Thrombocytopenias)

These disorders are defined by a drop in total platelet count, driven either by immune destruction or consumption within microthrombi:

• Immune Thrombocytopenic Purpura (ITP):
  An autoimmune condition where anti-GpIIb/IIIa antibodies opsonize platelets, leading to their premature destruction by splenic macrophages. Frequently triggered by viral infections in children (acute, self-limiting form) or presents chronically in adult females. Bone marrow aspiration reveals increased megakaryocytes attempting to compensate.
  
• Thrombotic Thrombocytopenic Purpura (TTP):
  Driven by a severe deficiency or inhibition of the ADAMTS13 enzyme (the von Willebrand factor-cleaving protease). Lacking this enzyme, uncleaved large vWF multimers accumulate, causing unchecked microvascular platelet aggregation and thrombi. This consumption drives thrombocytopenia and shears passing erythrocytes, causing Microangiopathic Hemolytic Anemia (MAHA).

  • Classic Pentad: Neurological symptoms, Renal failure, Fever, Thrombocytopenia, and Microangiopathic hemolytic anemia.

  
• Hemolytic Uremic Syndrome (HUS):
  Predominantly seen in children following gastrointestinal infection with Shiga-like toxin-producing E. coli O157:H7. The toxin damages renal endothelial cells, triggering localized microthrombi formation. Presents with the triad of thrombocytopenia, hemolytic anemia (schistocytes), and acute renal failure, usually without the prominent neurological symptoms seen in TTP.

2. Qualitative Platelet Disorders (Functional Defects)

In these conditions, the overall platelet count is completely normal, but specific structural defects alter normal adhesion, aggregation, or activation processes:

• Bernard-Soulier Syndrome: An autosomal recessive genetic deficiency of the **Glycoprotein Ib (GpIb)** receptor, preventing platelets from adhering to subendothelial von Willebrand factor. On a peripheral blood smear, it characteristically displays **giant platelets** (often the size of normal red blood cells) alongside mild thrombocytopenia.
• Glanzmann Thrombasthenia: An autosomal recessive genetic deficiency of the **Glycoprotein IIb/IIIa (GpIIb/IIIa)** receptor, preventing fibrinogen bridging and normal platelet-to-platelet aggregation. The peripheral blood smear shows normally sized, well-isolated platelets that completely fail to clump together.
• Uremic Platelet Dysfunction: Acquired qualitative defect seen in patients with severe acute or chronic renal failure. Retained uremic toxins directly inhibit both platelet aggregation and adhesion capabilities. Platelet count, PT, and PTT remain entirely normal, while the bleeding time is elevated. It improves significantly following hemodialysis.

3. Differential Diagnostic Lab Profiles

Distinguishing between quantitative defects, qualitative defects, and complex mixed states requires analyzing a complete primary coagulation panel alongside ristocetin agglutination assays: